0001209191-12-037627.txt : 20120709
0001209191-12-037627.hdr.sgml : 20120709
20120709162041
ACCESSION NUMBER: 0001209191-12-037627
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120705
FILED AS OF DATE: 20120709
DATE AS OF CHANGE: 20120709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 12953551
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2012-07-05
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2012-07-05
4
M
0
4000
15.60
A
636895
D
Common Stock
2012-07-05
4
S
0
4000
55.55
D
632895
D
Common Stock
13286
I
401(k)
Common Stock
300000
I
Common Stock held in trust.
Employee Stock Option (right to buy)
15.60
2012-07-05
4
M
0
4000
0.00
D
2013-01-17
Common Stock
4000
102951
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $55.55 (range $55.35 to $55.91).
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Common stock held in grantor retained annuity trusts.
Fully vested.
Valerie L. Andrews, Attorney-In-Fact
2012-07-09